IITZ-01 is primarily utilized in the field of medicinal chemistry due to its potent biological activity. It is extensively studied for its role as an inhibitor targeting specific enzymes or proteins involved in disease pathways. Researchers have explored its potential in treating various conditions, particularly in oncology, where it has shown promise in disrupting cancer cell proliferation. Additionally, its application extends to anti-inflammatory and antimicrobial research, where it is tested for its efficacy in combating infections and reducing inflammation. The compound’s unique structure allows it to interact with biological targets with high specificity, making it a valuable candidate for drug development and therapeutic interventions. Ongoing studies aim to optimize its pharmacokinetic properties and evaluate its safety profile for potential clinical use.